Mucosal Chemokine CCL27 Adjuvant Uniquely Improves Mucosal Responses to SARS-CoV-2 synDNA Antigens Providing Heterologous Protection Against Delta Variant Challenge

Gary, E. N.; Tursi, N. J.; Warner, B.; Parzych, E. M.; Ali, A. R.; Smith, T. R. F.; Broderick, K. E.; Kobasa, D.; Patel, A.; Kulp, D. W.; Weiner, D. B.

Gary, E. N.; Tursi, N. J.; Warner, B.; Parzych, E. M.; Ali, A. R.; Smith, T. R. F.; Broderick, K. E.; Kobasa, D.; Patel, A.; Kulp, D. W.; Weiner, D. B..

Molecular Therapy ; 30(4):233-234, 2022.

Article in English | English Web of Science | ID: covidwho-1880250

Keywords

Biotechnology & Applied Microbiology; Genetics & Heredity; Research &; Experimental Medicine

Search on Google

XML

Collection: Databases of international organizations Database: English Web of Science Topics: Variants Language: English Journal: Molecular Therapy Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

XML